Top Trends Transforming the Automated Compounding Devices Market Landscape in 2025: Innovations In IV Robotic Technology For Hospital Pharmacies

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Automated Compounding Devices Industry Market Size Be by 2025?
The market for automated compounding devices has seen significant expansion in the past few years. The market size is projected to increase from $2.36 billion in 2024 to $2.51 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. The historical growth of this market can be credited to factors such as the high prevalence of chronic conditions, a growing elderly population, development in healthcare facilities, regulatory mandates, and a rise in medication mistakes.

What's the Long-Term Growth Forecast for the Automated Compounding Devices Market Size Through 2029?
Expectations are high for a significant increase in the market size of automated compounding devices within the next few years. The market is projected to reach $3.3 billion by 2029 with a 7.1% CAGR. This anticipated growth during the forecast period can be linked to an increase in cancer cases, worldwide healthcare expansion, a heightened emphasis on patient safety, supportive regulations, and a growing focus on sustainability. Key trends for the forecast period encompass telemedicine, distance healthcare, advancements in artificial intelligence, digitization in the healthcare sector, and instantaneous monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

What Are the Key Growth Drivers Fueling the Automated Compounding Devices Market Expansion?
The growth of the automated compounding devices market is anticipated to be propelled by the rising amount of personalized medicines. Personalized medicine consists of healthcare decisions, tactics, interventions, and treatments designed to match each patient's unique characteristics. The expansion of personalized medicines can be attributed to a superior understanding of genetics, specific patient data, and regulatory backing. Automated compounding devices (ACDs) are valuable tools in personalized medicine as they allow for the exact preparation of individualized medication formulas based on specific patient requirements. These machines automate the task of combining different pharmaceutical components in accurate proportions, a vital aspect of generating personalized treatments. For example, according to the American non-profit organization, the Personalized Medicine Coalition, 16 new personalized treatments for patients suffering from rare ailments were approved by the FDA in 2023, a significant increase from just six in 2022. Consequently, the growth of the automated compounding devices market is being fuelled by the rise in personalized medicines.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Automated Compounding Devices Market?
Leading organizations in the automated compounding device market are investing in innovative technologies like robotic compounding to minimize medication blunders and elevate patient safety, thereby gaining increased customer reliability, adhering to regulatory rules, and securing a competitive edge. Robotic compounding technology provides accurate and automated preparation, as well as combining of pharmaceutical compounds through sophisticated robotic systems, thus amplifying accuracy, productivity, and safety in medication formulation. For instance, Omnicell Inc., a healthcare technology firm based in the US, introduced the IVX Station, a novel automated compounding device, in March 2022. This groundbreaking solution is designed to broaden the adoption of IV robotic technology in the wider market, thereby boosting patient safety, precision, cost-effectiveness, supply chain control, and regulation adherence. The IVX Station delivers three times the efficiency of existing IV robotic systems, features a highly dependable design to reduce downtime, and preserves a small footprint well-suited to pharmacy workflows.

How Is the Automated Compounding Devices Market Segmented?
The automated compounding devices market covered in this report is segmented -

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp

Which Companies Are Leading the Charge in Automated Compounding Devices Market Innovation?
Major companies operating in the automated compounding devices market are McKesson Corporation, Amerisource Bergen Corporation, Medtronic PLC, Becton Dickinson and Company, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, Grifols International S.A., Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Cantel Medical Corp., Fagron N.V., Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group S.p.A., ARxIUM Inc., Codonics Inc., Apexus Inc., Equashield LLC, Yuyama Mfg Co. Ltd., Shanghai Weibond Technology Co. Ltd., Quirem Medical B.V

Which Regions Are Leading the Global Automated Compounding Devices Market in Revenue?
North America was the largest region in the automated compounding devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18231

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.